Mirae Asset Global Investments Co., Ltd. - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
Mirae Asset Global Investments Co., Ltd. ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$8,390,523
-10.9%
184,854
+10.3%
0.02%
-10.0%
Q2 2023$9,412,922
+21.6%
167,596
-2.1%
0.02%
+11.1%
Q1 2023$7,741,882
+16.4%
171,167
+4.6%
0.02%
+5.9%
Q4 2022$6,650,422
-39.7%
163,602
-3.1%
0.02%
-43.3%
Q3 2022$11,029,000
+22.7%
168,775
+14.1%
0.03%
+30.4%
Q2 2022$8,991,000
-32.0%
147,946
-29.8%
0.02%
+64.3%
Q1 2022$13,230,000
+40.3%
210,764
+69.3%
0.01%
-30.0%
Q4 2021$9,432,000
-4.9%
124,477
+40.4%
0.02%
-20.0%
Q3 2021$9,923,000
-14.3%
88,648
+23.9%
0.02%
-21.9%
Q2 2021$11,580,000
+33.0%
71,529
+0.1%
0.03%
+6.7%
Q1 2021$8,710,000
+44.2%
71,482
+81.1%
0.03%
+36.4%
Q4 2020$6,042,000
+84.8%
39,467
+1.0%
0.02%
+37.5%
Q3 2020$3,269,000
+67.4%
39,086
+47.1%
0.02%
+33.3%
Q2 2020$1,953,000
+275.6%
26,580
+116.6%
0.01%
+200.0%
Q1 2020$520,000
-22.0%
12,271
+12.0%
0.00%0.0%
Q4 2019$667,000
+75.5%
10,954
+18.2%
0.00%
+33.3%
Q3 2019$380,0009,2640.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2021
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders